Researchers generate iPSCs to further treatments for lung disease

A team of researchers from Boston University's Centre for Regenerative Medicine and the Pulmonary Centre have generated 100 new lines of human induced pluripotent stem cells (iPSC) from individuals with lung diseases, including cystic fibrosis and emphysema. The new stem cell lines could possibly lead to new treatments for these debilitating diseases. The findings, which appear in the current issue of Stem Cells, demonstrate the first time lung disease-specific iPSC have been created in a lab...

Read the whole article on

More from